Related Experiment Video
Updated: Jun 19, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases
Piotr Chrusciel1, Aleksander Goch, Maciej Banach
1Department of Cardiology and Cardiac Surgery, Military University Hospital No. 10 with a Polyclinic in Bydgoszcz, Bydgoszcz, Poland.
Insights
Circadian rhythms significantly impact hemostasis, increasing cardiovascular event risk in the morning. These daily variations in blood clotting factors and platelet activity are crucial for understanding morning heart attack and stroke incidence.
Area of Science:
- Circadian Biology
- Hemostasis and Thrombosis
- Cardiovascular Medicine
Background:
- Cardiovascular events exhibit a pronounced morning peak, potentially linked to circadian variations in hemostasis.
- Daily fluctuations in von Willebrand factor (vWF), platelet count, and platelet aggregability are observed.
- Coagulation and fibrinolysis markers show distinct 24-hour patterns, influencing morning cardiovascular risk.
Purpose of the Study:
- To review the circadian rhythms of key hemostatic components.
- To explore the relationship between daily hemostatic changes and the morning incidence of cardiovascular events.
- To highlight alterations in circadian hemostasis patterns in individuals with health issues.
Main Methods:
- Systematic review of existing literature on circadian variations in hemostasis.
- Analysis of 24-hour periodicity in endothelium, platelets, coagulation, and fibrinolysis.
- Comparison of circadian hemostatic patterns in healthy subjects versus those with health problems.
Main Results:
- Circadian variability noted in vWF, platelet number (peak afternoon), and platelet aggregability (peak morning).
- Elevated morning levels of coagulation markers (fragment 1+2, factor VIIa, fibrinogen) and PAI-1 activity.
- Coagulation inhibitors (protein C, antithrombin III, TFPI) show peak activity in the morning; fibrinolytic activators lack periodicity.
Conclusions:
- Circadian changes in the hemostatic system, particularly morning increases in prothrombotic factors, contribute to elevated cardiovascular event risk.
- Disrupted circadian hemostasis patterns in unhealthy individuals may exacerbate cardiovascular risk.
- Understanding these diurnal rhythms is vital for cardiovascular event prevention strategies.
Abstract:
The highest risk of cardiovascular events is in the morning, which may be associated with circadian changes in hemostasis. There is a 10% circadian variability in von Willebrand factor (vWF). Circadian periodicity has been noted for both the number of platelets and their aggregability. The highest number of platelets was in the afternoon, while most studies observed an increase in platelet aggregation in the morning. Platelet activity has also been linked with physical activity after waking up. The highest values of coagulation system markers such as fragment 1+2, factor VIIa, and fibrinogen have been recorded in the late morning. Also, coagulation inhibitors such as protein C, antithrombin III, and a tissue factor pathway inhibitor are most active at this time of day. The levels of plasminogen and its activators (alpha 2-antiplasmin, urokinase-like plasminogen activator) do not undergo circadian periodicity, in contrast to changes in tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 levels (PAI-1). The most intensive activity of the fibrinolytic system inhibitor PAI-1 has been noted in the morning. The 24-h changes in the hemostatic system observed in healthy subjects often did not occur in individuals with health problems. The results of various studies suggest that circadian changes in the hemostatic system increase the incidence of cardiovascular events in the morning. This review considers the circadian rhythms of individual components involved in hemostasis (endothelium, platelets, coagulation, and fibrinolysis).
Related Concept Videos
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Anticoagulant Drugs: Low-Molecular-Weight Heparins